Khoo US - Search Results

1

Androgen Receptor as an Emerging Feasible Biomarker for Breast Cancer.

You CP, Leung MH, Tsang WC, Khoo US, Tsoi H. You CP, et al. Among authors: khoo us. Biomolecules. 2022 Jan 4;12(1):72. doi: 10.3390/biom12010072. Biomolecules. 2022. PMID: 35053220 Free PMC article. Review.

2

SpliceArray profiling of breast cancer reveals a novel variant of NCOR2/SMRT that is associated with tamoxifen resistance and control of ERα transcriptional activity.

Zhang L, Gong C, Lau SL, Yang N, Wong OG, Cheung AN, Tsang JW, Chan KY, Khoo US. Zhang L, et al. Among authors: khoo us. Cancer Res. 2013 Jan 1;73(1):246-55. doi: 10.1158/0008-5472.CAN-12-2241. Epub 2012 Nov 1. Cancer Res. 2013. PMID: 23117886

3

BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer.

Gong C, Man EPS, Tsoi H, Lee TKW, Lee P, Ma ST, Wong LS, Luk MY, Rakha EA, Green AR, Ellis IO, Lam EW, Cheung KL, Khoo US. Gong C, et al. Among authors: khoo us. Clin Cancer Res. 2018 Aug 1;24(15):3681-3691. doi: 10.1158/1078-0432.CCR-17-2259. Epub 2018 Feb 2. Clin Cancer Res. 2018. PMID: 29420220 Free PMC article.

4

Phosphorylation independent eIF4E translational reprogramming of selective mRNAs determines tamoxifen resistance in breast cancer.

Gong C, Tsoi H, Mok KC, Cheung J, Man EPS, Fujino K, Wong A, Lam EWF, Khoo US. Gong C, et al. Among authors: khoo us. Oncogene. 2020 Apr;39(15):3206-3217. doi: 10.1038/s41388-020-1210-y. Epub 2020 Feb 17. Oncogene. 2020. PMID: 32066877 Free PMC article.

5

A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2.

Leung MH, Tsoi H, Gong C, Man EP, Zona S, Yao S, Lam EW, Khoo US. Leung MH, et al. Among authors: khoo us. Cancers (Basel). 2020 Feb 26;12(3):533. doi: 10.3390/cancers12030533. Cancers (Basel). 2020. PMID: 32110852 Free PMC article.

6

Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer.

Tsoi H, Man EPS, Chau KM, Khoo US. Tsoi H, et al. Among authors: khoo us. Cancers (Basel). 2021 Mar 25;13(7):1511. doi: 10.3390/cancers13071511. Cancers (Basel). 2021. PMID: 33806019 Free PMC article.

7

KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer.

Tsoi H, Man EP, Leung MH, Mok KC, Chau KM, Wong LS, Chan WL, Chan SY, Luk MY, Cheng CN, Khoo US. Tsoi H, et al. Among authors: khoo us. Clin Transl Med. 2021 Oct;11(10):e554. doi: 10.1002/ctm2.554. Clin Transl Med. 2021. PMID: 34709749 Free PMC article. No abstract available.

8

Repurposing hyperpolarization-activated cyclic nucleotide-gated channels as a novel therapy for breast cancer.

Mok KC, Tsoi H, Man EP, Leung MH, Chau KM, Wong LS, Chan WL, Chan SY, Luk MY, Chan JYW, Leung JKM, Chan YHY, Batalha S, Lau V, Siu DCW, Lee TKW, Gong C, Khoo US. Mok KC, et al. Among authors: khoo us. Clin Transl Med. 2021 Nov;11(11):e578. doi: 10.1002/ctm2.578. Clin Transl Med. 2021. PMID: 34841695 Free PMC article.

9

Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer.

Tsoi H, Shi L, Leung MH, Man EPS, So ZQ, Chan WL, Khoo US. Tsoi H, et al. Among authors: khoo us. Life (Basel). 2022 Jan 10;12(1):93. doi: 10.3390/life12010093. Life (Basel). 2022. PMID: 35054486 Free PMC article.

10

Targeting Ribosome Biogenesis to Combat Tamoxifen Resistance in ER+ve Breast Cancer.

Tsoi H, You CP, Leung MH, Man EPS, Khoo US. Tsoi H, et al. Among authors: khoo us. Cancers (Basel). 2022 Feb 28;14(5):1251. doi: 10.3390/cancers14051251. Cancers (Basel). 2022. PMID: 35267559 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters